Skip to main content
Clinical Trials/NCT04328935
NCT04328935
Unknown
Not Applicable

A Feasibility Study for Written Exposure Therapy for Patients With Post-traumatic Stress Disorder in a Regular Health Care Setting

Karolinska Institutet1 site in 1 country12 target enrollmentOctober 27, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post Traumatic Stress Disorder
Sponsor
Karolinska Institutet
Enrollment
12
Locations
1
Primary Endpoint
The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)
Last Updated
4 years ago

Overview

Brief Summary

To investigate if written exposure therapy is feasible for patients with post-traumatic stress disorder

Detailed Description

A non-inferiority trial in JAMA Psychiatry showed that written exposure therapy (WET) was non-inferior to a gold standard CBT treatment. In comparison to other trauma-focused CBT protocols, WET generally demands less therapist-time, and specifically, less than half compared to CBT that consists of 12 weekly sessions á 60 minutes. The aim of this study is to translate and replicate these results in a Swedish context. This first step is a small feasibility trial which will guide a subsequent large-scale trial.

Registry
clinicaltrials.gov
Start Date
October 27, 2020
End Date
April 27, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erik Andersson

Principal investigator

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • Meet criteria for PTSD.
  • If taking psychotropic medication, then the dose must be stable for at least 4 weeks prior to study entry.
  • ≥ 18 years
  • Situated in Sweden
  • Be able to express themselves in Swedish, both in verbally and written form.
  • Informed consent

Exclusion Criteria

  • Other serious comorbidity as primary concern (ongoing substance dependence, untreated bipolar disorder, psychotic symptoms, severe depression, borderline personality disorder, high suicidal risk according to the MINI)
  • Ongoing CBT for trauma
  • Ongoing trauma-related threat (e.g. living with a violent spouse)

Outcomes

Primary Outcomes

The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

Time Frame: Time Frame: Baseline, week 5 and follow-up at 6 months

Change in symptoms of post traumatic stress from baseline to post treatment and follow up (6 months). The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that assesses the presence and severity of PTSD symptoms. All items are scored on a 0-4 scale. Higher score indicate worse severity

Secondary Outcomes

  • Euroqol, EQ-5D(Time Frame: Baseline, week 5 and follow-up at 6 months)
  • Montgomery Åsberg Depression Rating Scale - Self-report (MADRS-S)(Time Frame: Baseline, week 5 and follow-up at 6 months)

Study Sites (1)

Loading locations...

Similar Trials